Pharmanutra S.p.A.: Business Overview, Financials & Competitive Analysis
Pharmanutra S.p.A. scores 7/10 on the AskCyborg Cyborg Score (Strong). Pharmanutra is well-positioned in the growing nutraceutical sector with a comprehensive portfolio and global distribution network across regulated and emerging markets. The company has a market capitalization of $739M with trailing twelve month revenue of $141M. Strong market position in nutraceuticals with diversified product portfolio and international presence. Moderate valuation.
What is Pharmanutra S.p.A.'s industry? Pharmanutra S.p.A. (pharmanutra.it) operates in Pharmaceutical & Nutraceutical - Specialty Supplements & Medical Devices. AskCyborg classifies Pharmanutra S.p.A. under Pharmaceutical & Nutraceutical - Specialty Supplements & Medical Devices in its company registry.
Pharmanutra S.p.A. is a pharmaceutical and nutraceutical company that researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, ...
Cyborg Score thesis
Pharmanutra is well-positioned in the growing nutraceutical sector with a comprehensive portfolio and global distribution network...
Read the full analyst-debate transcript →Get the Latest Pharmanutra S.p.A. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreePharmanutra S.p.A. Overview
Pro stress-test →Pharmanutra S.p.A. is a pharmaceutical and nutraceutical company that researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company covers all stages of product development from design, formulation and registration to marketing, distribution and training of commercial representatives.
Strategic Profile
Pro stress-test →Pharmanutra produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries, offering iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products as well as medical instrumentation and software for body bioimpedance analysis. The company focuses on studying and producing formulations that are backed up in scientific research.
Competitive Landscape
Pro stress-test →Pharmanutra competes in the fragmented nutraceutical and specialty pharmaceutical market against larger multinational companies and regional players. The company's competitive advantage lies in scientific formulation expertise, established relationships with healthcare professionals, and integrated manufacturing capabilities. Focus on niche therapeutic areas (iron deficiency, joint health, sports nutrition) positions it favorably against broader competitors.
Industry Context
Pharmanutra S.p.A. operates in Pharmaceutical & Nutraceutical - Specialty Supplements & Medical Devices.
Key facts
Founded: 2003 · Headquarters: Pisa, Italy · Revenue: $141M · Market cap: $739M